16 05, 2023 Daniela Massi et al., Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group. adlitterio663392023-10-17T09:13:02+02:00 Leggi di più
6 04, 2015 Daniela Massi et al., Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. Modern Pathology Diatech Pharmacogenetics2017-08-08T12:22:12+02:00 Leggi di più
